United States Antimony Corporation provided an operational update on its Fostung Project, an intermediate-stage tungsten exploration asset in Ontario, Canada. The company made available a Technical Report Summary (TRS) on the Fostung Tungsten Property, effective January 31, 2026, prepared in accordance with subpart 1300 of Regulation S‑K.
The TRS was completed by SRK Consulting (Canada), Inc., which is identified as a Qualified Person under the regulation. The Fostung Project consists of 50 contiguous single-cell mining claims covering 1,109 hectares and hosts a skarn-type tungsten (scheelite) deposit with associated molybdenum, copper, and silver mineralization. The project is directly owned by UAMY Cobalt Corporation, a wholly owned subsidiary of the company.
The company includes a standard cautionary note that the operational update and related TRS contain forward-looking statements subject to various risks and uncertainties, and it incorporates the TRS as Exhibit 99 to this report.
United States Antimony Corporation (USAC) is soliciting proxies for its virtual 2026 Annual Meeting to be held on June 12, 2026. Shareholders of record as of April 15, 2026 may vote on three proposals: election of seven directors, approval to increase authorized common shares, and ratification of Assure CPA, LLC as independent auditors. The Board recommends voting FOR all proposals. The proxy materials and the 2025 Annual Report on Form 10-K are available at www.proxyvote.com.
UNITED STATES ANTIMONY CORP executive Melissa Pagen, President & COO of BRZ, reported a disposition of 89,004 shares of common stock on March 23, 2026. The weighted average price was $9.14 per share, with individual trades ranging from $9.05 to $9.26. After this transaction, she directly holds 44,825 shares of the company’s stock.
UNITED STATES ANTIMONY CORP director and officer Lloyd Bardswich reported a disposition of 59,872 shares of Common Stock back to the issuer. The transaction, coded as a Disposition to issuer, was recorded at $8.98 per share. Following this transaction, Bardswich directly holds 877,483 shares of the company’s Common Stock.
UNITED STATES ANTIMONY CORP director Blaise A. Aguirre reported multiple dispositions of common stock back to the company. On March 31, 2026, he disposed of several blocks totaling 27,000 shares at prices between $8.20 and $8.26 per share, each coded as a “Disposition to issuer” (D). After these transactions, he directly held 845,754 shares of United States Antimony common stock.
UNITED STATES ANTIMONY CORP director and executive officer Lloyd Bardswich reported two dispositions of common stock back to the issuer. On March 26, 2026, he disposed of 46,674 shares at $9.34 per share, and on March 27, 2026, he disposed of 36,181 shares at $9.05 per share.
Across both transactions, a total of 82,855 common shares were returned to the company. Following these issuer dispositions, Bardswich directly holds 937,355 shares of UNITED STATES ANTIMONY CORP common stock, indicating he retains a substantial equity position after the reported activity.
UNITED STATES ANTIMONY CORP director Blaise A. Aguirre reported returning shares of common stock to the company. On March 24, 2026, he disposed of 20,000 shares at $9.16 per share, a transaction classified as a "Disposition to issuer".
On March 27, 2026, he reported two additional dispositions to the issuer of 6,339 shares at $8.78 per share and 5,373 shares at $8.77 per share. After these transactions, he directly held 872,754 shares of common stock, indicating that only a small portion of his overall position was returned to the company.
UNITED STATES ANTIMONY CORP granted equity awards to Chairman & CEO Gary C. Evans as part of compensation. He received a time-based restricted stock unit (RSU) award covering 304,524 shares of Common Stock under the Amended & Restated 2023 Equity Incentive Plan. One-third, or 101,508 shares, vest on January 15, 2026, with additional one-third portions vesting on January 15, 2027 and January 18, 2028, subject to continued service. He also received a stock option for 308,133 shares of Common Stock with a conversion or exercise price of $8.29 per share, which can vest upon meeting specified performance measures at any time during its 10-year term, also contingent on continued service. These are grant/award acquisitions, not open-market purchases or sales.
United States Antimony Corp granted equity awards to John C. Gustavsen, its President, Antimony Division. He received a restricted stock unit award covering 50,754 shares of Common Stock, vesting in three equal installments on January 15, 2026, January 15, 2027, and January 18, 2028, subject to continued service. He was also granted a stock option over 61.627 shares of Common Stock at an exercise price of $8.2900 per share, which vests upon achieving specified performance measures at any time during its 10-year term, also conditioned on continued service. These are compensation-related grants, not open-market purchases or sales.
United States Antimony Corp Schedule 13G/A: The Vanguard Group reports 0 shares beneficially owned, representing 0% of the common stock. The amendment explains an internal realignment effective January 12, 2026, under SEC Release No. 34-39538, causing certain Vanguard subsidiaries or business divisions to report separately. The filing is signed by Ashley Grim, Head of Global Fund Administration, dated 03/27/2026.